Freightos Leads The Pack With Two Other Promising Penny Stocks

As the U.S. stock market navigates a period of uncertainty with the Federal Reserve's interest rate decision looming, investors are keenly focused on potential opportunities within various sectors. Penny stocks, though often considered relics of past trading days, remain relevant as they highlight smaller or less-established companies that can offer substantial value. By identifying those with strong financials and growth potential, investors can uncover hidden gems in this niche segment of the market.

Top 10 Penny Stocks In The United States

Click here to see the full list of 344 stocks from our US Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Freightos (CRGO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Freightos Limited operates a vendor-neutral booking and payment platform for international freight, with a market cap of $164.11 million.

Operations: Freightos Limited does not report specific revenue segments.

Market Cap: $164.11M

Freightos Limited, with a market cap of US$164.11 million, is navigating the penny stock landscape through strategic partnerships and digital innovations in freight logistics. Recent collaborations with Jambojet Cargo and Pattaya Airways expand its digital booking platform's reach across Africa and Southeast Asia, enhancing service efficiency. Despite being unprofitable and experiencing net losses of US$4.96 million in Q3 2025, Freightos forecasts annual revenue growth to US$29.6 million for the year. The company remains debt-free with sufficient cash runway for over a year, supported by strong asset coverage of liabilities and stable weekly volatility at 9%.

• Click here and access our complete financial health analysis report to understand the dynamics of Freightos.
• Learn about Freightos' future growth trajectory here.

DocGo (DCGO)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: DocGo Inc. offers mobile health and medical transportation services in the United States and the United Kingdom, with a market cap of $102.70 million.

Operations: The company generates revenue from Mobile Health Services, contributing $168.46 million, and Transportation Services, which account for $199.64 million.

Market Cap: $102.7M

DocGo Inc., with a market cap of US$102.70 million, is navigating the penny stock environment by leveraging its mobile health and medical transportation services in the U.S. and U.K. Despite recent financial challenges, including a net loss of US$27.77 million for Q3 2025, DocGo maintains strong asset coverage with short-term assets exceeding liabilities and more cash than debt. The company is actively seeking acquisitions to bolster its technology-driven healthcare solutions, evidenced by its strategic acquisition of SteadyMD. While unprofitable, DocGo's focus on expanding integrated care services positions it for potential growth within the evolving healthcare landscape.

• Navigate through the intricacies of DocGo with our comprehensive balance sheet health report here.
• Review our growth performance report to gain insights into DocGo's future.

Baozun (BZUN)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Baozun Inc. provides end-to-end e-commerce solutions in China, with a market cap of approximately $176.46 million.

Operations: The company's revenue is primarily derived from its E-Commerce segment, generating CN¥8.21 billion, and its Brand Management segment, contributing CN¥1.72 billion.

Market Cap: $176.46M

Baozun Inc., with a market cap of approximately $176.46 million, trades significantly below its estimated fair value, presenting potential opportunities in the penny stock sector. Despite being unprofitable, Baozun has robust short-term asset coverage exceeding both short and long-term liabilities and more cash than debt. Recent earnings showed revenue growth to CN¥2.16 billion for Q3 2025 compared to the previous year, though net losses widened to CN¥107.11 million. The management team is experienced with an average tenure of 3.8 years; however, challenges remain as profitability has not been achieved yet despite positive revenue trends.

• Jump into the full analysis health report here for a deeper understanding of Baozun.
• Understand Baozun's earnings outlook by examining our growth report.

Where To Now?

• Reveal the 344 hidden gems among our US Penny Stocks screener with a single click here.
• Seeking Other Investments? Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com